CRISPR Therapeutics (NASDAQ:CRSP) Posts Earnings Results, Beats Estimates By $0.41 EPS
CRISPR Therapeutics (NASDAQ:CRSP – Get Free Report) issued its quarterly earnings data on Tuesday. The company reported ($1.01) earnings per share for the quarter, beating analysts’ consensus estimates of ($1.42) by $0.41, Briefing.com reports. The company had revenue of $0.60 million during the quarter, compared to the consensus estimate of $6.65 million. During the same […]
More Stories
OFS Credit Company, Inc. (NASDAQ:OCCI) Shares Bought by Graypoint LLC
Graypoint LLC raised its stake in OFS Credit Company, Inc. (NASDAQ:OCCI – Free Report) by 4.8% in the third quarter,...
NextEra Energy, Inc. (NYSE:NEE) Shares Bought by Graypoint LLC
Graypoint LLC raised its position in NextEra Energy, Inc. (NYSE:NEE – Free Report) by 7.3% in the 3rd quarter, according...
Insider Selling: McDonald’s Co. (NYSE:MCD) EVP Sells $441,470.49 in Stock
McDonald’s Co. (NYSE:MCD – Get Free Report) EVP Marion K. Gross sold 1,499 shares of the stock in a transaction...
Walkner Condon Financial Advisors LLC Invests $425,000 in Vanguard ESG U.S. Corporate Bond ETF (BATS:VCEB)
Walkner Condon Financial Advisors LLC purchased a new stake in Vanguard ESG U.S. Corporate Bond ETF (BATS:VCEB – Free Report)...
Arturo R. Moreno Buys 250,000 Shares of Clear Channel Outdoor Holdings, Inc. (NYSE:CCO) Stock
Clear Channel Outdoor Holdings, Inc. (NYSE:CCO – Get Free Report) major shareholder Arturo R. Moreno purchased 250,000 shares of Clear...
Aware (NASDAQ:AWRE) Earns Buy Rating from Analysts at StockNews.com
StockNews.com assumed coverage on shares of Aware (NASDAQ:AWRE – Free Report) in a research report sent to investors on Tuesday....